These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 26130113)
21. Ceramide in lipid emulsions used in parenteral nutrition: an innocent bystander? Groener JE; Serlie MJ; Poppema A; Mirzaian M; Aerts JM JPEN J Parenter Enteral Nutr; 2011 Mar; 35(2):270-1. PubMed ID: 21378257 [TBL] [Abstract][Full Text] [Related]
22. Intravenous Lipid Emulsions in the Prevention and Treatment of Liver Disease in Intestinal Failure. Rochling FA Nutrients; 2021 Mar; 13(3):. PubMed ID: 33801970 [TBL] [Abstract][Full Text] [Related]
23. The intestinal microbiome and paediatric liver disease. Leung DH; Yimlamai D Lancet Gastroenterol Hepatol; 2017 Jun; 2(6):446-455. PubMed ID: 28497760 [TBL] [Abstract][Full Text] [Related]
24. Intestinal failure-associated liver disease (IFALD): insights into pathogenesis and advances in management. Lee WS; Chew KS; Ng RT; Kasmi KE; Sokol RJ Hepatol Int; 2020 May; 14(3):305-316. PubMed ID: 32356227 [TBL] [Abstract][Full Text] [Related]
25. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation. Cowles RA; Ventura KA; Martinez M; Lobritto SJ; Harren PA; Brodlie S; Carroll J; Jan DM J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585 [TBL] [Abstract][Full Text] [Related]
26. The Gut Microbiome in Patients with Intestinal Failure: Current Evidence and Implications for Clinical Practice. Neelis E; de Koning B; Rings E; Wijnen R; Nichols B; Hulst J; Gerasimidis K JPEN J Parenter Enteral Nutr; 2019 Feb; 43(2):194-205. PubMed ID: 30070709 [TBL] [Abstract][Full Text] [Related]
27. The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD). Chang MI; Puder M; Gura KM Nutrients; 2012 Nov; 4(12):1828-50. PubMed ID: 23363993 [TBL] [Abstract][Full Text] [Related]
28. Composite Lipid Emulsion for the Infant at Risk of Intestinal Failure-associated Liver Disease: The Canadian Perspective. Silverman JA; Turner JM; Wales PW J Pediatr Gastroenterol Nutr; 2020 Sep; 71(3):283-287. PubMed ID: 32459744 [TBL] [Abstract][Full Text] [Related]
39. Children With Intestinal Failure Undergoing Intestinal Rehabilitation Are at Risk for Essential Fatty Acid Deficiency. Gunnar R; Lumia M; Pakarinen M; Merras-Salmio L JPEN J Parenter Enteral Nutr; 2018 Sep; 42(7):1203-1210. PubMed ID: 29701873 [TBL] [Abstract][Full Text] [Related]
40. Lipids and liver dysfunction in patients receiving parenteral nutrition. Gabe SM Curr Opin Clin Nutr Metab Care; 2013 Mar; 16(2):150-5. PubMed ID: 23340009 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]